Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
|
23910690 |
2013 |
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes.
|
11133775 |
2001 |
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes.
|
11133775 |
2001 |
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease.
|
10706888 |
2000 |
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Lupus Erythematosus, Systemic
|
0.370 |
Biomarker
|
disease |
CTD_human |
Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively.
|
28135245 |
2017 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
A variant amino acid in a frequent NCF1 allele causing deficient ROS production leads to an exaggerated type I interferon (IFN) response, earlier disease onset, and higher susceptibility to SLE.
|
31303528 |
2019 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Blood neutrophils from Ncf1-mutated and human individuals with SLE exhibited exuberant spontaneous NET formation.
|
28515366 |
2017 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.
|
31705128 |
2019 |
Lupus Erythematosus, Systemic
|
0.370 |
Biomarker
|
disease |
BEFREE |
To further underline the systemic lupus erythematosus (SLE)-related autoimmune process, we show that naïve Ncf1(m1J) mutated mice, similar to SLE patients, suffer from inflammatory kidney disease with IgG and C3 deposits in the glomeruli.
|
24787605 |
2014 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively.
|
28135245 |
2017 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
OBJECTIVES: A single nucleotide polymorphism in the NCF1 gene (NCF1-339, rs201802880), encoding NADPH oxidase type II subunit NCF1/p47<sup>phox</sup>, reducing production of reactive oxygen species (ROS) is strongly associated with the development of systemic lupus erythematosus (SLE).
|
31704719 |
2020 |
Lupus Erythematosus, Systemic
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
In addition, the NCF1-339 T allele was associated with a younger age at diagnosis of SLE; mean age 30.3 compared with 35.9, p=2.0×1<sup>-6</sup>.
|
28606963 |
2017 |
Rheumatoid Arthritis
|
0.350 |
PosttranslationalModification
|
disease |
BEFREE |
P47-phox phosphorylation was enhanced after cytokine-treatment in RA and OA cells, suggesting a PKC-mediated up-regulation of NADPH oxidase.
|
17122966 |
2006 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
BEFREE |
This is the first finding of genetic association of NCF1 with RA.
|
21728841 |
2012 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
CTD_human |
From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies.
|
12833524 |
2003 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
BEFREE |
On the other hand, immunoblot analysis revealed that co-treatment with RA and resveratrol caused remarkable accumulation of protein levels of gp91-phox (to 4-fold), p22-phox (to 5-fold) and p47-phox (to 4-fold) compared with those of the RA-treatment alone.
|
29183727 |
2018 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
BEFREE |
We found that NCF1 and NADPH oxidase 2 (NOX2) complex-derived ROS is an important regulator of several chronic inflammatory disorders by using models for rheumatoid arthritis, multiple sclerosis, psoriasis and psoriasis arthritis, gout, and lupus.
|
26683156 |
2016 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
CTD_human |
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases.
|
28135245 |
2017 |
Rheumatoid Arthritis
|
0.350 |
Biomarker
|
disease |
BEFREE |
The use of linkage analysis and positional cloning of genes in animal models for RA resulted in the identification of one of the genes regulating severity of arthritis in rats and mice, the Ncf1 gene.
|
16724810 |
2006 |
Aortic Aneurysm, Abdominal
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
After two weeks of Ang II infusion, the incidence rate of AAA substantially dropped from 76.5% in Ang II infused hph-1 mice (n=34) to 11.1%, 15.0%, 9.5% and 0% in hph-1-NOX1 (n=27), hph-1-NOX2 (n=40), hph-1-p47phox (n=21), and hph-1-NOX4 (n=33) double mutant mice, respectively.
|
27912196 |
2017 |
Aortic Aneurysm, Abdominal
|
0.310 |
Biomarker
|
disease |
CTD_human |
Deletion of p47phox attenuated the pressor response to Ang II; however, coinfusion of phenylephrine with Ang II, which restored the Ang II pressor response, did not alter the protective effects of p47phox deletion on AAA formation.
|
16864727 |
2006 |
Alloxan Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
|
14871415 |
2004 |
Alloxan Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
|
16380483 |
2006 |